AVITA Medical, Inc.
ASX: AVH.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Cary G. Vance
- Employees
- 260
- Headquarters
- Valencia, United States
- IPO year
- 1993
- Market cap
- A$146.0M
- Website
- https://www.avitamedical.com
Loading AVH…
Loading profile data…Frequently asked questions about AVH
What does AVITA Medical, Inc. (AVH.AX) do?
AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and pro...
Where does AVH.AX trade?
AVITA Medical, Inc. (AVH.AX) trades on the Australian Securities Exchange.
What sector is AVH.AX in?
AVITA Medical, Inc. (AVH.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of AVITA Medical, Inc.?
Cary G. Vance is the chief executive officer of AVITA Medical, Inc. (AVH.AX).
Where is AVITA Medical, Inc. headquartered?
AVITA Medical, Inc. is headquartered in United States.
Does AVH.AX pay a dividend?
AVITA Medical, Inc. (AVH.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AVH.AX go public?
AVITA Medical, Inc. (AVH.AX) completed its initial public offering in 1993.